Summit Therapeutics Inc vs Workday Inc — how do they compare? Summit Therapeutics Inc trades at $14.57 (market cap $10.48B), while Workday Inc trades at $141 (market cap $36.36B). The key difference: Workday Inc is far larger — about 3.5× Summit Therapeutics Inc's market cap, and Workday Inc is trading nearer its 52-week high, Summit Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| SMMT | WDAY | |
|---|---|---|
Market Cap | $10.48B | $36.36B |
Sector | Health | Technology |
52-Week High | $29.32 | $247.69 |
52-Week Low | $13.05 | $112.55 |
Enterprise Value | $9.90B | $35.81B |
Trailing returns across standard periods
Latest headlines on both assets
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →Workday is a software company that offers human capital management, or HCM, financial management, and business planning solutions. Known for being a cloud-only software provider, Workday is headquartered in Pleasanton, California. Founded in 2005, Workday now employs over 12,000 employees.
Read more on WDAY →